Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled Trials
Top Cited Papers
- 1 July 2003
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 160 (7) , 1209-1222
- https://doi.org/10.1176/appi.ajp.160.7.1209
Abstract
OBJECTIVE: The authors performed a systematic review and meta-analysis of studies of the potential of new-generation antipsychotic drugs to improve adherence and decrease relapse rates in patients ...Keywords
This publication has 26 references indexed in Scilit:
- Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trialsSchizophrenia Research, 2002
- Does cognitive function improve with quetiapine in comparison to haloperidol?Schizophrenia Research, 2002
- Clozapine and Haloperidol in Moderately Refractory SchizophreniaArchives of General Psychiatry, 2001
- Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia.Psychopharmacology, 2000
- Neuropsychological Change in Early Phase Schizophrenia During 12 Months of Treatment With Olanzapine, Risperidone, or HaloperidolArchives of General Psychiatry, 2000
- A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophreniaSchizophrenia Research, 1999
- Review Do atypical antipsychotic medications favorably alter the long-term course of schizophrenia?Journal of Psychiatric Research, 1998
- Neuroleptic Withdrawal in Schizophrenic PatientsArchives of General Psychiatry, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Why Do Schizophrenic Patients Refuse to Take Their Drugs?Archives of General Psychiatry, 1974